HI
BPTH

Human Investing’s Bio-Path Holdings Inc BPTH Stock Holding History

Human Investing’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$14K – 300
2021
Q1 		$14K Hold
100
– – ﹤0.01% 223
2020
Q4 		$7K Hold
100
– – ﹤0.01% 241
2020
Q3 		$8K Hold
100
– – ﹤0.01% 240
2020
Q2 		$10K Buy
+100
New +$10.4K ﹤0.01% 225

Other funds holding BPTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IF
Ironwood Financial Tucson, Arizona $639M AUM 19.03% 1-Year Est. Return

Human Investing's BPTH Position: Q2 2021 in Review

Human Investing sold out of Bio-Path Holdings Inc (BPTH) in Q2 2021, closing a stake of 100 shares — an estimated $14K sold.

Human Investing first reported a position in BPTH in Q2 2020 and held it in 4 quarters. The position peaked at $14K in Q1 2021. 17 funds tracked by Wall St. Rank hold BPTH as of Q2 2021.

  • Human Investing reported no remaining Bio-Path Holdings Inc position as of Q2 2021 after selling out during the quarter.
  • Human Investing sold 100 Bio-Path Holdings Inc shares in Q2 2021, an estimated $14K.
  • Human Investing first reported a position in Bio-Path Holdings Inc in Q2 2020 and held it in 4 quarters.
  • Human Investing's Bio-Path Holdings Inc position peaked at $14K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2021.

Based on Human Investing's 13F filing for Q2 2021, filed 2 Aug 2021.